Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 13, Issue 1, pp. 120-129
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 5, 2014
- Revision received August 18, 2014
- Accepted August 31, 2014
- Published first September 17, 2014.
Article Versions
- Previous version (September 17, 2014 - 07:27).
- You are viewing the most recent version of this article.
Copyright & Usage
©2014 American Association for Cancer Research.
Author Information
- Daniel L. Menezes*,
- Jenny Holt,
- Yan Tang,
- Jiajia Feng,
- Paul Barsanti,
- Yue Pan,
- Majid Ghoddusi,
- Wei Zhang,
- George Thomas,
- Jocelyn Holash,
- Emma Lees, and
- Lorena Taricani*
- ↵*Corresponding Authors:
Lorena Taricani, E-mail: lorenataricani{at}yahoo.com; and Daniel Menezes, dmenezes1{at}gmail.com. Phone: 510-923-3965; Fax: 510-923-3360; Novartis Institutes for BioMedical Research, 4560 Horton Street, Mailstop 4.3, Emeryville, CA 94608.
D.L. Menezes and J. Holt contributed equally to the article.
January 2015
Volume 13, Issue 1
Volume 13, Issue 1
A Synthetic Lethal Screen Reveals Enhanced Sensitivity to ATR Inhibitor Treatment in Mantle Cell Lymphoma with ATM Loss-of-Function
Jump to section
Advertisement